
- Applied Clinical Trials-03-01-2011
- Volume 20
- Issue 3
Palm Beach CRO and AOBO Form Partnership
Chinese pharmaceutical company forms alliance with American CRO.
Numerous US CROs now offer their services to American, European, and Japanese pharmaceutical companies conducting clinical trials in China. In a twist to this rising trend, American Oriental Bioengineering Inc. (AOBO), a Chinese pharmaceutical company, has formed an alliance to have an American CRO, Palm Beach Clinical Research Organization (Palm Beach CRO), conduct clinical trials of its drugs in the United States.
"We plan to develop one of our drug candidates in the United States. We would like to work with an American CRO to conduct our clinical study here," said Tom Du, MD, PhD, Chief Technology Officer at AOBO.
The agreement was formally signed at the 2011 US-China Trade and Economic Cooperation Forum on January 21, 2011. At the event, AOBO was the only Chinese pharmaceutical company to sign an agreement with an American company, and Palm Beach CRO was the only American CRO to sign an agreement with a Chinese pharmaceutical company.
"It's outstanding for Palm Beach CRO to be able to be chosen as the one and only CRO for AOBO," said Arthur Simon, PhD, President of Palm Beach CRO. "It's a major honor."
Based on this agreement, Palm Beach CRO will provide services such as site selection, protocol preparation, and data analysis, among other responsibilities.
Palm Beach CRO is currently conducting a Phase II study for a drug candidate for the treatment of overactive bladder with urge urinary incontinence and frequency (
According to Simon, sites have been chosen and enrollment is on schedule, with subjects being dosed at some sites.
"We expect clinical sites of the upmost highest levels, and to do clinical studies with physicians around the country at the highest level," said Simon. "The end result is to take the product to the next level—Phase III."
Palm Beach CRO hopes to have data ready by the third quarter of 2011.—Kayda Norman
Articles in this issue
over 14 years ago
Applied Clinical Trials Digital Edition - March 2011, Supplementover 14 years ago
Applied Clinical Trials Digital Edition - March 2011over 14 years ago
ACT coverover 14 years ago
Business and News Update March 2011over 14 years ago
Cancer Trials: Raising Accrual Ratesover 14 years ago
Revisions to the Clinical Trials Directiveover 14 years ago
Low Hanging Fruit in the Fight Against Inefficiencyover 14 years ago
Researchers Explore Uses of Health System Dataover 14 years ago
Biomarkers and Targeted Therapies Usageover 14 years ago
ACT CoverNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.